Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw

Mint 2018-02-08

Views 3

Kiran Mazumdar-Shaw talks about Biocon's strategy after Pfizer?s exit and why she thinks the regulatory environment is holding back biotech growth.

Share This Video


Download

  
Report form